These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 31624135

  • 1. Comparative Docking to Distinct G Protein-Coupled Receptor Conformations Exclusively Yields Ligands with Agonist Efficacy.
    Scharf MM, Bünemann M, Baker JG, Kolb P.
    Mol Pharmacol; 2019 Dec; 96(6):851-861. PubMed ID: 31624135
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ligand-binding affinity of alternative conformers of human β2 -adrenergic receptor in the presence of intracellular loop 3 (ICL3) and their potential use in virtual screening studies.
    Dilcan G, Doruker P, Akten ED.
    Chem Biol Drug Des; 2019 May; 93(5):883-899. PubMed ID: 30637937
    [Abstract] [Full Text] [Related]

  • 6. Allosteric nanobodies reveal the dynamic range and diverse mechanisms of G-protein-coupled receptor activation.
    Staus DP, Strachan RT, Manglik A, Pani B, Kahsai AW, Kim TH, Wingler LM, Ahn S, Chatterjee A, Masoudi A, Kruse AC, Pardon E, Steyaert J, Weis WI, Prosser RS, Kobilka BK, Costa T, Lefkowitz RJ.
    Nature; 2016 Jul 21; 535(7612):448-52. PubMed ID: 27409812
    [Abstract] [Full Text] [Related]

  • 7. Ligand-stabilized conformational states of human beta(2) adrenergic receptor: insight into G-protein-coupled receptor activation.
    Bhattacharya S, Hall SE, Li H, Vaidehi N.
    Biophys J; 2008 Mar 15; 94(6):2027-42. PubMed ID: 18065472
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Multiparametric homogeneous method for identification of ligand binding to G protein-coupled receptors: receptor-ligand binding and β-arrestin assay.
    Kopra K, Kainulainen M, Mikkonen P, Rozwandowicz-Jansen A, Hänninen P, Härmä H.
    Anal Chem; 2013 Feb 19; 85(4):2276-81. PubMed ID: 23330639
    [Abstract] [Full Text] [Related]

  • 17. Cell-based assays and molecular dynamics analysis of a boron-containing agonist with different profiles of binding to human and guinea pig beta2 adrenoceptors.
    Soriano-Ursúa MA, Bello M, Hernández-Martínez CF, Santillán-Torres I, Guerrero-Ramírez R, Correa-Basurto J, Arias-Montaño JA, Trujillo-Ferrara JG.
    Eur Biophys J; 2019 Jan 19; 48(1):83-97. PubMed ID: 30386878
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Identifying ligand binding conformations of the β2-adrenergic receptor by using its agonists as computational probes.
    Isin B, Estiu G, Wiest O, Oltvai ZN.
    PLoS One; 2012 Jan 19; 7(12):e50186. PubMed ID: 23300522
    [Abstract] [Full Text] [Related]

  • 20. Differences between G-Protein-Stabilized Agonist-GPCR Complexes and their Nanobody-Stabilized Equivalents.
    Saleh N, Ibrahim P, Clark T.
    Angew Chem Int Ed Engl; 2017 Jul 24; 56(31):9008-9012. PubMed ID: 28481446
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.